Stockreport

Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]

Cyclacel Pharmaceuticals, Inc.  (CYCC) 
Last cyclacel pharmaceuticals, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.cyclacel.com/investor-relations
PDF Reported EPS is $-6.23, expectations were $-6.35. CYCC isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter ( see the details here [Read more]